Who says women are not as good as men? A few days ago, Forbes released "2018 China's most outstanding business women's list", Huawei's chairman Sun Yafang won the crown, CITIC Bank Chairman Li Qingping and Gree Electric Chairman and President Dong Mingzhu ranked second and third. This is the fourth time Forbes released the list, and in this list, eight female executives in the pharmaceutical industry entered the list. The author below will bring you a detailed introduction. Xie Qirun, Chairman of China Biopharmaceutical Board of Directors <br> Xie Qirun is the executive vice president of Zhengda Group and the daughter of Xie Bing, Chairman of Zhengda Pharmaceutical Group. He is currently Chairman of the Board of Directors of China Biopharmaceuticals. Xie Qirun’s father, Xie Bing, ranked 1678 on the global rich list with China’s $1.2 billion in assets. Acne Pimple Patch,Diy Pimple Patch,Pimple Band Aid,Peace Out Acne Dots Wenzhou Celecare Medical Instruments Co.,Ltd , https://www.wzcelecare.com
As a listed company of Zhengda Pharmaceutical Group in Hong Kong, China Biopharmaceutical Co., Ltd. has achieved steady growth in research and development, production, marketing and other aspects since its listing in Hong Kong in September 2000. Related products are in liver diseases, targeted drugs, The medical field such as geriatric diseases, cardiovascular and cerebrovascular diseases has further consolidated its market superiority and become a well-known pharmaceutical enterprise group in the Chinese pharmaceutical market.
GE Greater China President and CEO Duan Xiaolu <br> Duan Xiaoyu joined GE in 1996. In July 2014, Duan Xiaoyu became the President and CEO of GE Greater China. She is the first CEO of GE China and the first female CEO of GE China. Duan Xiaolu has extensive experience in the GE and China markets and has a deep understanding of how to help clients succeed.
GE Healthcare has created a new era of medical care by providing innovative medical technologies and services. A wide range of expertise in medical imaging, information technology, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical technology, operational excellence and total operational solutions.
Nestlé Asia, Oceania, Africa President Gong Wanren Gong Wanren has served as President of NCH Marketing Services USA, Borden Burton Foods and Kraft Foods as senior management positions. Chief Financial Officer of Nestlé Group, Senior Vice President and Chief Financial Officer of Wal-Mart International, Executive Vice President of Global E-Commerce, Executive Vice President of Nestlé Group.
Nestlé has crossed the border in recent years. In 2016, Nestlé acquired a medical device company for $130 million. And in recent years, Nestlé's several actions have shown that medical care is a potential area for its future stage of cloth and power. Some professionals have analyzed this. Nestlé's layout in the medical industry is not a step-by-step approach, but a step-by-step approach.
Xie Bing , President of Johnson & Johnson China In August 2015, Xie Bing officially joined Johnson & Johnson. Prior to this, she worked for P&G for many years and became the president of brand operations in Greater China. In China's fast-changing and unique market, Xie Bing said that how to keep up with the market and consumer changes or lead consumers in the first place requires a good methodology and effective management system and rapid The ability to react.
Johnson & Johnson, a company with more than 100 years of history, is a comprehensive health care company with a wide range of businesses. Johnson & Johnson China was established in 1992. It is the first wholly-owned enterprise established by Johnson & Johnson in mainland China. It is committed to the production and promotion of high-quality personal hygiene products for people of all ages and promotes the improvement of family health care in China.
Wang Aijun , Chairman of Plum Blossoms , from January 1998 to March 2008, Wang Aijun served as Assistant Sales Manager of Hebei Langfang Meihua MSG Co., Ltd.; from March 2008 to April 2009, he served as General Manager of Hebei Meihua MSG Co., Ltd.; Chairman of Meihua Biotechnology Group Co., Ltd.
Meihua started from the production of MSG in 2002 and quickly developed into one of the world's largest MSG manufacturers. It is the largest amino acid producer in China and an important member of the global bio-fermentation field. The main business covers two major areas of amino acids and condiments. It has four major industrial groups: food additives, pharmaceutical intermediates, feed additives and condiments.
Zhu Lixian , President of Bayer Greater China In September 2014, Zhu Lixian officially served as the president of Bayer Group Greater China. After she took office, she faced the divestiture of materials technology business, the global merger and acquisition of Merck health care products, and the confrontation of China In the acquisition and integration of the pharmaceutical industry, in the face of such complicated and challenging work, Zhu Lixian has allowed Bayer China to successfully transition through the transition period without affecting business development.
Bayer is a multinational company whose core competencies in life sciences include healthcare and agriculture. Bayer's products and services are dedicated to benefiting people and improving people's quality of life. At the same time, Bayer creates value through technological innovation, business growth and an efficient profit model.
Guo Shuqin, vice chairman and general manager of Jilin Jidong <br> Guo Shuqin pays attention to technological innovation and management innovation, continuously improves product quality standards and scientific and technological content, and organically combines GMP and ERP information management systems to strengthen enterprise management. At present, Guo Shuqin has comprehensively improved the quality of employees and helped the company to develop rapidly, so that the interests of shareholders and the interests of enterprises are guaranteed.
The predecessor of Jilin Jidong Pharmaceutical Group Co., Ltd. was the state-owned Yanbian Dunhua Deer Farm established in 1957. After decades of development, the company has created four core competencies: a management team with the same heart and mind, leading the advanced technology of modernization of traditional Chinese medicine, brand-new sails without wind and self-raising, and raw material bases in Changbai Mountain.
Shandong Renkang Vice Chairman and General Manager Zhang Renhua <br> According to relevant media reports, Zhang Renhua is the vice chairman and general manager of Shandong Ruikang Pharmaceutical Co., Ltd. In early 1995, the company achieved sales of 1 billion yuan in 2008. In 2012, it achieved operating income of 4.622 billion yuan and accumulated more than 5 million yuan in five years. Zhang Renhua once ranked #48 in the “2015 Hurun Women's Rich List†with a wealth of 7.5 billion yuan.
Shandong Ruikang Pharmaceutical Co., Ltd. is a joint-stock enterprise established in 2004, focusing on the pharmaceutical circulation industry. At present, Shandong Ruikang Pharmaceutical Co., Ltd. is striding forward in the forefront of the same industry in the province with its own advantages, and has become one of the pillar enterprises in the pharmaceutical distribution field in Shandong Province.